Around January 24, 2020 in Canada, the International Vaccine Center (VIDO-InterVac) at the University of Saskatchewan announced that it had begun work on a vaccine, with human testing expected to begin in 2021.
Tarehe 24 Januari 2020 nchini Kanada, Kituo cha Kimataifa cha Chanjo (VIDO-InterVac) katika Chuo Kikuu cha Saskatchewan kilitanganza kuanza kushughulikia chanjo, kikilenga kuanza upimaji kwa mwadamu mnamo 2021.